Connection

Pamela Morris to Proprotein Convertase 9

Back to Details
This is a "connection" page, showing publications Pamela Morris has written about Proprotein Convertase 9.
Pamela Morris
Connection Strength
0.040
Proprotein Convertase 9
  1. Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial. Circulation. 2019 01 15; 139(3):410-412.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.